Protagonist Therapeutics Inc (PTGX) Stock Analysis
Verdict: WATCH (do not buy)
PTGX's pipeline momentum is priced at a steep 118.8x P/E, where severe insider selling capping upside counteracts analyst optimism.
Investment score: 58/100
Analysis as of
Is Protagonist Therapeutics Inc stock worth reviewing? AI model thesis
The model rates PTGX a HOLD. High pipeline expectations and analyst price targets ($169.38 average) are offset by elevated valuation multiples (118.8x P/E) and persistent insider sales near $148.50-$149.11.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 80/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 55/100 (weight 15%)
Protagonist Therapeutics Inc opportunities and risks
What speaks for PTGX
- Rusfertide Commercialization Milestones in PV
What speaks against PTGX
- Heavy Insider Selling Capping Near-Term Upside
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PTGX | 118.8x | 33.0x | 104.0x | 99.9% | 29.4% | 1.4% |
| KRYS | 41.3x | 22.8x | 44.2x | 93.3% | 54.8% | 2.6% |
| KYMR | n/a | 94.9x | n/a | 102.0% | -285.4% | -2.4% |
| CYTK | n/a | 122.9x | n/a | 85.0% | -1259.9% | -6.7% |
| ARWR | n/a | 14.5x | n/a | 100.0% | -47.8% | -0.8% |
| PCVX | n/a | 0.0x | n/a | 0.0% | 0.0% | -13.7% |
| Peer median | n/a | 22.8x | n/a | 93.3% | -47.8% | -2.4% |
Frequently asked questions about Protagonist Therapeutics Inc (PTGX)
Is PTGX stock a good investment?
The cached TradeMates AI model rates Protagonist Therapeutics Inc as WATCH (do not buy) with an investment score of 58/100. The model rates PTGX a HOLD. High pipeline expectations and analyst price targets ($169.38 average) are offset by elevated valuation multiples (118.8x P/E) and persistent insider sales near $148.50-$149.11. This is algorithmic model output, not personal investment advice.
Is PTGX stock a buy?
The TradeMates model verdict for PTGX is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.